Two Sigma Advisers’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $94.6K | Buy |
|
|||||
|
2025
Q3 | $19K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $156K | Sell |
|
|||||
|
2021
Q1 | $1.57M | Buy |
|
|||||
|
2020
Q4 | $741K | Buy |
|
|||||
|
2020
Q3 | $344K | Buy |
|
|||||
|
2020
Q2 | $258K | Buy |
|
|||||
|
2020
Q1 | $55K | Sell |
|
|||||
|
2019
Q4 | $138K | Sell |
|
|||||
|
2019
Q3 | $139K | Buy |
|
|||||
|
2019
Q2 | $183K | Buy |
|
|||||
|
2019
Q1 | $221K | Buy |
|
|||||
|
2018
Q4 | $72K | Buy |
|
|||||
|
2018
Q3 | $158K | Buy |
|